Amyris Inc. (NASDAQ: AMRS)’s stock price has increased by 9.24 compared to its previous closing price of 1.19. Nevertheless, the company has seen a gain of 15.04% in its stock price over the last five trading days. The Wall Street Journal reported on 08/14/21 that A Money Manager’s Hand Sanitizer Company Just Sold For Millions
Is It Worth Investing in Amyris Inc. (NASDAQ: AMRS) Right Now?
, and the 36-month beta value for AMRS is at 1.17. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 as “hold,” and 1 as “sell.”
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
The average price suggested by analysts for AMRS is $3.40, which is $1.97 above the current market price. The public float for AMRS is 233.91M, and currently, shorts hold a 22.09% of that float. The average trading volume for AMRS on March 16, 2023 was 5.87M shares.
AMRS’s Market Performance
The stock of Amyris Inc. (AMRS) has seen a 15.04% increase in the past week, with a -17.72% drop in the past month, and a -21.21% fall in the past quarter. The volatility ratio for the week is 8.68%, and the volatility levels for the past 30 days are at 9.01% for AMRS. The simple moving average for the last 20 days is 3.09% for AMRS stock, with a simple moving average of -40.53% for the last 200 days.
Analysts’ Opinion of AMRS
ROTH Capital gave a rating of “Neutral” to AMRS, setting the target price at $2 in the report published on August 10th of the previous year.
AMRS Trading at -10.21% from the 50-Day Moving Average
After a stumble in the market that brought AMRS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -74.76% of loss for the given period.
Volatility was left at 9.01%, however, over the last 30 days, the volatility rate increased by 8.68%, as shares sank -19.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.69% lower at present.
During the last 5 trading sessions, AMRS rose by +14.60%, which changed the moving average for the period of 200-days by -51.50% in comparison to the 20-day moving average, which settled at $1.2452. In addition, Amyris Inc. saw -15.03% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at AMRS starting from Kung Frank, who sale 200,000 shares at the price of $3.50 back on Sep 21. After this action, Kung Frank now owns 0 shares of Amyris Inc., valued at $700,000 using the latest closing price.
Kung Frank, the Director of Amyris Inc., sale 400,000 shares at $3.60 during a trade that took place back on Sep 20, which means that Kung Frank is holding 36,488 shares at $1,440,000 based on the most recent closing price.
Stock Fundamentals for AMRS
Current profitability levels for the company are sitting at:
- -48.31 for the present operating margin
- +51.77 for the gross margin
The net margin for Amyris Inc. stands at -79.12. Equity return is now at value 222.60, with -40.20 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.37.
In conclusion, Amyris Inc. (AMRS) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.